A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages.
We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.